Dana-Farber Research News 01.01.2026 - Takeaways - MDSpire

Dana-Farber Research News 01.01.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from December 1 - 15.

  • By

  • January 1, 2026

  • 23 min

Share

  • 1

    Dana-Farber's Research News highlights faculty publications from December 1-15, 2025, focusing on significant research advancements.

  • 2

    Genomic evolution and environmental factors play crucial roles in the progression from precursor conditions to multiple myeloma.

  • 3

    Circulating tumor DNA (ctDNA) positivity is a strong predictor of worse disease-free and overall survival in stage III colon cancer patients.

  • 4

    Adjuvant celecoxib improves survival outcomes in stage III colon cancer patients with positive ctDNA status.

  • 5

    The treatment landscape for chronic lymphocytic leukemia has evolved with the introduction of noncovalent Bruton tyrosine kinase inhibitors.

Original Source(s)

Dana-Farber Research News 01.01.2026

  • by

  • January 1, 2026

Related Content

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma

Artificial intelligence for optimization of immunotherapy: current applications and transformative potential

PD-1 inhibitor combined with chemoradiotherapy in two cases of ovarian cancer brain metastases: a case report